These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8432411)

  • 21. Insulin resistance in maturity onset diabetes of the young.
    Mohan V; Sharp PS; Aber VR; Mather HM; Kohner EM
    Diabete Metab; 1987 Jun; 13(3):193-7. PubMed ID: 3301443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
    Bratusch-Marrain P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Apr; 99(7):211-6. PubMed ID: 3296467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced glucose-induced thermogenesis is present in noninsulin-dependent diabetes mellitus without obesity.
    Gumbiner B; Thorburn AW; Henry RR
    J Clin Endocrinol Metab; 1991 Apr; 72(4):801-7. PubMed ID: 2005204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects.
    Fendri S; Debussche X; Puy H; Vincent O; Marcelli JM; Dubreuil A; Lalau JD
    Diabete Metab; 1993; 19(2):245-9. PubMed ID: 8339856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
    Puhakainen I; Koivisto VA; Yki-Järvinen H
    J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenobarbital treatment enhances insulin mediated glucose metabolism in man.
    Lahtela JT; Särkkä P; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):215-26. PubMed ID: 6377421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic extraction of insulin in non-insulin dependent diabetes. Comparative study of obese and non-obese patients.
    Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
    Diabete Metab; 1984 Sep; 10(3):175-80. PubMed ID: 6386556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential infusions of glucose and insulin at prefixed rates: a simple method for assessing insulin sensitivity and insulin responsiveness.
    Heine RJ; Bilo HJ; van der Meer J; van der Veen EA
    Diabetes Res; 1986 Nov; 3(9):453-61. PubMed ID: 3549121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin action in black Americans with NIDDM.
    Banerji MA; Lebovitz HE
    Diabetes Care; 1992 Oct; 15(10):1295-302. PubMed ID: 1425092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity to insulin in type I diabetes. Preliminary report].
    Pernet A; Kuntschen F; Trimble ER; Assal JP; Hahn C; Renold AE
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1917-9. PubMed ID: 6364337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
    Hollenbeck CB; Chen YD; Reaven GM
    Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo metabolic defects in non-insulin-dependent diabetes mellitus.
    Bonadonna RC
    Horm Res; 1993; 39 Suppl 3():102-6. PubMed ID: 8262485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
    Campbell PJ; Mandarino LJ; Gerich JE
    Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.